⌘K

Login Start Free

Home/Filings/4/0000899243-20-011277

4//SEC Filing

Chapman Marcus 4

Accession 0000899243-20-011277

CIK 0001609809other

View on SEC.gov Company Profile

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 4:10 PM ET

Size

5.4 KB

Accession

0000899243-20-011277

Insider Transaction Report

Form 4

Period: 2020-04-22

Seres Therapeutics, Inc.MCRB

See Remarks

Transactions

Award
STOCK OPTION (RIGHT TO BUY)
2020-04-22+18,596→ 18,596 total
Exercise: $3.74Exp: 2030-04-21→ Common Stock (18,596 underlying)

Footnotes (1)

[F1]The option will vest in full on April 22, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1

filerCIK 0001770404

Filing Metadata

Form type: 4
Filed: Apr 23, 8:00 PM ET
Accepted: Apr 24, 4:10 PM ET
Size: 5.4 KB

View on SEC.gov